Suzuken News

Suzuken: change report

Nov 18 14:55

Suzuken: Notice regarding the results of treasury stock repurchase through off-the-counter share purchase transactions (ToSTnet-3)

Nov 15 10:00

Suzuken: Notice regarding the purchase of treasury shares through an off-site share repurchase transaction (TostNet3)

Nov 14 16:00

Suzuken: Confirmation letter

Nov 14 12:30

Suzuken: Half Year Report - Term 79 (2024/04/01 - 2025/03/31)

Nov 14 12:27

Suzuken: Notice regarding decisions on matters relating to share buybacks and cancellation of treasury stock

Nov 12 14:00

Suzuken: Summary of financial results for the 2nd quarter (interim period) of the fiscal year ending 2025/3 [Japanese GAAP] (Consolidated)

Nov 12 14:00

Suzuken: Notice regarding differences between consolidated earnings forecasts and actual values for the 2nd quarter (interim period) cumulative period of the fiscal year ending 2025/3 and revisions to the full-year consolidated earnings forecast for the fiscal year ending 2025/3

Nov 12 14:00

Suzuken: Notice regarding the relocation of the Saga Sales Division Karatsu Branch

Nov 11 13:00

Suzuken: Change Report

Oct 25 13:30

Suzuken: Notice regarding executive personnel affairs at subsidiary companies

Oct 25 13:00

Suzuken: Notice regarding personnel changes at subsidiaries

Oct 1 13:00

Suzuken: Notice regarding executive officer personnel and personnel changes

Sep 27 13:00

Suzuken: Announcement of the start of in-home delivery service for the drug “Vesulemi Dermal Injection 250 μg Syringe/500 μg Syringe” for the treatment of polycythemia vera by Pharma Essencia Japan Co., Ltd.

Sep 25 13:00

Suzuken: Suzuken Group and Cancer Research Group Begin Joint Research on Evaluation of Cancer Medication Adherence at Akira Hospital - Utilizing the Newly Developed Medication Management System “CubiXXDT (Japan Version)”

Sep 25 13:00

Suzuken: Notice regarding integration of Wakayama Sales Division Kihoku Branch and relocation of Chiba Sales Department Matsudo Branch

Sep 25 13:00

Suzuken: Extraordinary Report

Aug 30 14:03

Suzuken: Notice Concerning the Recording of Extraordinary Profit (Gains on Sale of Investment Securities)

Aug 30 14:00

Suzuken: Consolidated financial results for the first quarter ending March 2025 (based on Japanese standards)

Aug 9 14:00

Suzuken: Change Report

Jul 30 09:27